What You Need to Know About Sangamo Biosciences' Surge

Results from a small, 14 person phase 1 trial suggest that while the drug doesn't eradicate HIV from patients, it may someday offer patients a functional cure that controls the disease enough for them to avoid continuous therapy.

http://ift.tt/1dJJlZl